PMID: 6164470Mar 15, 1981Paper

Radiation therapy of malignant melanomas: an evaluation of clinically used fractionation schemes

Cancer
A StraussA J Piro

Abstract

To assess the importance of radiation dose fraction size in the treatment of malignant melanomas, the records of 48 patients (83 sites) treated at Tufts-New England Medical Center from 1971 to 1979 have been retrospectively reviewed. During this period, the dose fractionation schemes evolved from standard fraction size to large-dose techniques. Radiation fraction size was observed to be the major factor in the clinical response of melanoma. Fractions of 600-800 rad resulted in the best overall response (80%). The rapid fractionation scheme of 800-400-400 rad on successive days resulted in intermediate response (58%) and may be useful for the palliative treatment of selected patients.

References

Jul 1, 1978·AJR. American Journal of Roentgenology·B EmamiA J Piro
Feb 11, 1975·Cancer·J J CostanziF C Delaney
Apr 1, 1974·Clinical Radiology·A SealyB Shepstone
Oct 1, 1971·The British Journal of Radiology·D L Dewey
Feb 15, 1963·Annals of the New York Academy of Sciences·W HELLRIEGEL

❮ Previous
Next ❯

Citations

Nov 1, 1996·Seminars in Surgical Oncology·R K Schmidt-Ullrich, C R Johnson
Apr 1, 1990·Journal of Surgical Oncology·M ChadhaL L Anderson
Dec 22, 2004·Current Treatment Options in Oncology·Terry A DayDeanne Lathers
Aug 21, 2007·Current Oncology Reports·Martin Majer, Wolfram E Samlowski
Feb 1, 1996·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·O P IsokangasS Pyrhönen
Mar 1, 1984·Clinical Radiology·M S Khan, W M Ross
Dec 1, 1984·Ophthalmology·S PackerP Salanitro
Oct 31, 2002·Seminars in Oncology·James G Douglas, Kim Margolin
Apr 13, 2004·Current Opinion in Oncology·Ahmad A Tarhini, Sanjiv S Agarwala
Jun 23, 2005·BMC Evolutionary Biology·Daniel L NickrentFrank E Anderson
Oct 7, 1998·Journal of Neurosurgery·F M SalpietroF Tomasello
Aug 1, 1982·The British Journal of Radiology·J S AdamJ Kirk
Sep 1, 1991·The British Journal of Radiology·R M Singhal, A Narayana
Jul 1, 1982·International Journal of Radiation Oncology, Biology, Physics·P J Selby, V D Courtenay
Aug 1, 1990·International Journal of Radiation Oncology, Biology, Physics·H McBrideJ Trent
Mar 1, 1984·International Journal of Radiation Oncology, Biology, Physics·J F Fowler
Jun 1, 1986·International Journal of Radiation Oncology, Biology, Physics·J Overgaard
Oct 1, 1985·International Journal of Radiation Oncology, Biology, Physics·J OvergaardM Overgaard
Mar 1, 1991·International Journal of Radiation Oncology, Biology, Physics·W T SauseJ Lipsett
Oct 1, 1988·International Journal of Radiation Oncology, Biology, Physics·W R RateA T Turrisi
Mar 1, 1986·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·J OvergaardH von der Maase
Jun 1, 1986·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·D Gonzalez GonzalezP Rümke
Jun 1, 2013·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Annette PflugfelderUNKNOWN German Society of Dermatology
Jul 12, 2011·Journal of Surgical Oncology·Kirsty U BoydClaire L F Temple
Jan 24, 2014·Journal of Surgical Oncology·Claire F Temple-OberleJ Gregory McKinnon
Jul 6, 2014·Journal of Surgical Oncology·Brett A ByersJ Greg McKinnon
Dec 1, 1992·Gynecologic Oncology·S B KristiansenD M Cohen
Nov 1, 1989·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·S M BentzenJ Meder
Mar 1, 1992·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·G StevensA Coates
Apr 15, 2003·The Surgical Clinics of North America·Richard Essner
May 15, 2003·The Surgical Clinics of North America·Matthew T Ballo, K Kian Ang
Jul 1, 1989·Cancer·L C HartmannB P O'Neill
May 1, 1988·Cancer·S Retsas, A R Gershuny
Jul 6, 2004·Arquivos de neuro-psiquiatria·Asdrubal FalavignaJosé Valentim Krindges Júnior
Jun 8, 2017·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Thomas K EigentlerClaus Garbe
Nov 1, 1993·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·R Ben-Yosef, D S Kapp
Jan 1, 1984·Acta Radiologica. Oncology·K BenediktsdóttirB Zetterlund
Jul 4, 2008·Cancer Control : Journal of the Moffitt Cancer Center·Lawrence B Berk
Feb 3, 2021·Journal of Cutaneous Medicine and Surgery·Sami KhouryGregory J McKinnon

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

International Journal of Radiation Oncology, Biology, Physics
P A LoboA M Kanji
International Journal of Radiation Oncology, Biology, Physics
L L Doss, N Memula
Cancer Treatment Reviews
A R Harwood, B J Cummings
© 2022 Meta ULC. All rights reserved